Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn:
”Attending the International Society on Thrombosis and Haemostasis (ISTH) Congress is always one of the highlights of my year ISTH 2026, and I was especially excited to be in Paris, France this year.
I had the privilege of presenting our latest work on ADAMTS13/VWF dysregulation in sepsis on behalf of my graduate student, Olamilekan George.
Throughout my career, ISTH has played a transformative role by fostering an exceptional global network of colleagues, hosting a vibrant and scientifically outstanding congress, championing diversity and inclusivity, and providing awards and opportunities that enable early-career investigators to participate and grow.
The Society has created an environment where scientists at every stage can connect, collaborate, and thrive, and I am grateful to be part of this remarkable community.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment